Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for FSIAD
NCT04433559Phase 3Unknown
- Sponsor
- Lidia Larrañaga
- Start
- Aug 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tadalafil in female sexual interest/arousal disorder (FSIAD), sponsored by Lidia Larrañaga. Status: unknown.
02
Drugs
tadalafil
03
Conditions
female sexual interest/arousal disorder (FSIAD)
Beyond the preview
Go deeper on NCT04433559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04433559.